Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01907100
Title Nintedanib (BIBF 1120) in Mesothelioma
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult
Covered Countries USA | TUR | SWE | POL | NOR | NLD | ITA | ISR | HRV | GBR | FRA | ESP | DNK | DEU | CZE | CAN | BEL | AUT | AUS | ARG


No variant requirements are available.